Leidos · 1 month ago
Senior Test Engineer 25k Sign On Bonus
Leidos has a new and exciting opportunity for a Senior Test Engineer in their Intelligence Sector & Analytics Business Area. The role involves designing and implementing test plans, performing user interface testing, and developing automation tests to support software development for the Intelligence Community.
ComputerGovernmentInformation ServicesInformation TechnologyNational SecuritySoftware
Responsibilities
Designing, developing, and implementing test plans, test cases, and test processes
Performing User Interface testing against requirements
Identifying data to be used during testing
Developing automation tests using Visual Studio (VS Code) and Cypress
Developing automation tests using Eclipse and Java
Working in GIT to push/pull automation test scripts
Experience in testing for accessibility
Defining test strategies for future capabilities
Managing project artifacts
Determining appropriate project methodologies and practices
Qualification
Required
Masters in Math, Science, Engineering, Statistics, Engineering Management or related discipline from an accredited college or university is required. Candidates without Masters Degrees will be considered on a case by case basis
Twelve or more years' directly related technical experience
Eight or more years of test engineering experience supporting programs and contracts of similar scope, type, and complexity is required
Clearance Required: Must have an active TS/SCI with Polygraph
Preferred
Experience with Atlassian Tool Suite (JIRA, Confluence)
Experience with manual testing and with using automated tools (e.g. Cypress, Visual Studio, Eclipse, Java)
Experience with regression and integration testing (in multiple environments)
GIT
Linux
Putty
Benefits
Paid Time Off
11 paid Holidays
401K with a 6% company match and immediate vesting
Flexible Schedules
Discounted Stock Purchase Plans
Technical Upskilling
Education and Training Support
Parental Paid Leave
Company
Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world’s most vexing challenges in national security and health.
Funding
Current Stage
Public CompanyTotal Funding
unknown2025-02-20Post Ipo Debt
2013-09-17IPO
Recent News
MarketScreener
2025-12-16
2025-12-16
Company data provided by crunchbase